1959
DOI: 10.1097/00000441-195908000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Some Cardiovascular Effects of Phenyl-2-Butyl-Norsuprifen Hydrochloride (Arlidin)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1963
1963
1966
1966

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Heretofore, knowledge of the hemodynamic effects of this agent in the normal subject has been limited to the 2 individuals described by Caliva and his co-workers. 1 Until adequate studies are reported, detailing the normal physiologic responses of pharmacologic agents, further clinical application of such drugs is limited to the experiences in various pathologic states. The data described herein suggest that an agent such as nylidrin may be of value in disease states other than peripheral arterial insufficiency associated with intermittent claudication.…”
Section: Discussionmentioning
confidence: 99%
“…Heretofore, knowledge of the hemodynamic effects of this agent in the normal subject has been limited to the 2 individuals described by Caliva and his co-workers. 1 Until adequate studies are reported, detailing the normal physiologic responses of pharmacologic agents, further clinical application of such drugs is limited to the experiences in various pathologic states. The data described herein suggest that an agent such as nylidrin may be of value in disease states other than peripheral arterial insufficiency associated with intermittent claudication.…”
Section: Discussionmentioning
confidence: 99%
“…It produces a marked effect on cardiac output, respiration, and peripheral resistance, mimicking the effects of beta adrenergic stimulation (Ahlquist, 1948) as produced by isoprenaline. Various authors have noted its selectively greater dilator effect in resting muscle compared to skin areas (Caliva, Eich, Taylor, and Lyons, 1959;Winsor, Hyman, and Knapp, 1960). It thus seemed to be worth investigating it further.…”
Section: Newer Vasodilators and Intermittent Claudicationmentioning
confidence: 99%